Intra-Cellular Therapies, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2013 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Intra-Cellular Therapies, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2013 to Q3 2024.
  • Intra-Cellular Therapies, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 28, 2024 was 106M shares, a 10.2% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 106M +9.78M +10.2% Oct 28, 2024 10-Q 2024-10-30
Q2 2024 106M +9.58M +9.97% Aug 5, 2024 10-Q 2024-08-07
Q1 2024 106M +9.65M +10.1% May 3, 2024 10-Q 2024-05-07
Q3 2023 96.2M +1.53M +1.62% Oct 31, 2023 10-Q 2023-11-02
Q2 2023 96.1M +1.69M +1.79% Aug 1, 2023 10-Q 2023-08-03
Q1 2023 95.9M +2.33M +2.49% May 2, 2023 10-Q 2023-05-04
Q3 2022 94.7M +13.2M +16.3% Nov 1, 2022 10-Q 2022-11-03
Q2 2022 94.4M +13.1M +16.1% Aug 5, 2022 10-Q 2022-08-09
Q1 2022 93.6M +12.4M +15.3% Feb 25, 2022 10-K 2022-03-01
Q3 2021 81.5M +1.31M +1.63% Nov 5, 2021 10-Q 2021-11-09
Q2 2021 81.3M +14M +20.9% Aug 6, 2021 10-Q 2021-08-09
Q1 2021 81.2M +15.1M +22.8% May 7, 2021 10-Q 2021-05-10
Q3 2020 80.2M +24.9M +45.1% Nov 6, 2020 10-Q 2020-11-09
Q2 2020 67.3M +12.1M +22% Aug 7, 2020 10-Q 2020-08-10
Q1 2020 66.1M +11M +20% Feb 28, 2020 10-K 2020-03-02
Q3 2019 55.3M +535K +0.98% Nov 4, 2019 10-Q 2019-11-05
Q2 2019 55.2M +464K +0.85% Aug 6, 2019 10-Q 2019-08-07
Q1 2019 55.1M +436K +0.8% Feb 25, 2019 10-K 2019-02-27
Q3 2018 54.7M +149K +0.27% Nov 7, 2018 10-Q 2018-11-07
Q2 2018 54.7M +11.3M +26% Aug 2, 2018 10-Q 2018-08-02
Q1 2018 54.7M +11.3M +25.9% Feb 28, 2018 10-K 2018-03-01
Q3 2017 54.6M +11.3M +26.1% Nov 8, 2017 10-Q 2017-11-08
Q2 2017 43.4M +173K +0.4% Aug 9, 2017 10-Q 2017-08-09
Q1 2017 43.4M +188K +0.43% May 9, 2017 10-Q 2017-05-10
Q3 2016 43.3M +246K +0.57% Nov 9, 2016 10-Q 2016-11-09
Q2 2016 43.3M +8.2M +23.4% Aug 4, 2016 10-Q 2016-08-04
Q1 2016 43.2M +8.3M +23.8% Apr 28, 2016 10-Q 2016-04-28
Q3 2015 43M +13.6M +46.3% Nov 4, 2015 10-Q 2015-11-05
Q2 2015 35.1M +5.67M +19.3% Aug 4, 2015 10-Q 2015-08-05
Q1 2015 34.9M +5.71M +19.5% Mar 11, 2015 10-K 2015-03-12
Q3 2014 29.4M +7.26M +32.8% Oct 31, 2014 10-Q 2014-11-03
Q2 2014 29.4M +24.4M +488% Aug 8, 2014 10-Q 2014-08-12
Q1 2014 29.2M Mar 15, 2014 10-K 2014-03-25
Q3 2013 22.1M Nov 4, 2013 10-Q 2013-11-05
Q2 2013 5M Jul 16, 2013 10-K 2013-07-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.